Even though magnesium pidolate changes the number of certain brain receptors, it does not change the actual levels of the neurotransmitters glutamate, GABA, or dopamine in human brain organoids.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether magnesium supplementation consistently fails to alter glutamate, GABA, or dopamine concentrations across human brain organoid models under standardized conditions.
A systematic review and meta-analysis of all published human brain organoid studies measuring glutamate, GABA, and dopamine levels after magnesium exposure, pooling data from at least 12 independent studies using identical ELISA or HPLC methods.
Whether magnesium pidolate or sulfate causes no change in neurotransmitter levels compared to control in human brain organoids.
A double-blind, randomized trial using 60 organoids assigned to 5 mM MgPid, 5 mM MgSO4, or control, with neurotransmitter levels measured via ELISA at 24, 48, and 72 hours, blinded to group, with primary outcome being concentration change.
Whether magnesium concentration over time correlates with stable neurotransmitter levels in organoids.
A longitudinal cohort study tracking 30 organoids exposed to 0, 1, 3, and 5 mM MgPid over 14 days, with daily neurotransmitter measurements to assess stability and potential delayed effects.
Whether magnesium concentration at a single time point is associated with neurotransmitter levels across diverse organoid lines.
A cross-sectional analysis of 70 organoids from different iPSC lines exposed to 0–10 mM MgPid for 4 days, with neurotransmitter levels measured at endpoint to assess correlation.
Whether organoids derived from individuals with neurotransmitter synthesis disorders show altered responses to magnesium.
A case series of 5–10 organoid lines derived from individuals with mutations in glutamate decarboxylase (GAD1) or tyrosine hydroxylase (TH), exposed to 5 mM MgPid, to assess whether neurotransmitter levels remain unchanged.